Express Scripts’ Coverage Of Sovaldi In 2015 “To Be Determined”
This article was originally published in The Pink Sheet Daily
Executive Summary
In releasing its list of drugs to be excluded from coverage in 2015, Express Scripts keeps the pressure on Gilead by waiting to decide on Sovaldi coverage until after it sees what other products FDA approves in the hepatitis C space. PBM turns down Zohydro ER; Advair Diskus regains coverage.